{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:26:29Z","timestamp":1781738789515,"version":"3.54.5"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2024.01826"],"award-info":[{"award-number":["2024.01826"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.actbio.2025.12.018","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T01:43:47Z","timestamp":1765417427000},"page":"296-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modeling the human bladder tissue using three dimensional in vitro approaches as a tool for drug screening platforms"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3058-2715","authenticated-orcid":false,"given":"Daniel","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5763-7553","authenticated-orcid":false,"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0001","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.addr.2012.08.010","article-title":"Collagen - emerging collagen based therapies hit the patient","volume":"65","author":"Abou Neel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2025.12.018_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/154564","article-title":"Tissue engineering of urinary bladder and urethra: advances from bench to patients","volume":"2013","author":"Orabi","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.actbio.2025.12.018_bib0003","series-title":"Principles of Regenerative Medicine","first-page":"1263","article-title":"Regenerative medicine of the bladder","author":"Zhang","year":"2019"},{"issue":"11","key":"10.1016\/j.actbio.2025.12.018_bib0004","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00345-018-2369-5","article-title":"Modeling human bladder cancer","volume":"36","author":"Ringuette-Goulet","year":"2018","journal-title":"World J. Urol."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0005","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.hoc.2021.02.004","article-title":"Diagnosis and staging of bladder cancer","volume":"35","author":"Ahmadi","year":"2021","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"19","key":"10.1016\/j.actbio.2025.12.018_bib0006","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0007","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/physiol.00036.2016","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology"},{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0008","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapalczynska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.actbio.2025.12.018_bib0009","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is it time to start transitioning from 2D to 3D cell culture?","volume":"7","author":"Caleb","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"22","key":"10.1016\/j.actbio.2025.12.018_bib0010","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1111\/febs.16778","article-title":"Recreating the extracellular matrix: novel 3D cell culture platforms in cancer research","volume":"290","author":"Kyriakopoulou","year":"2023","journal-title":"FEBS J."},{"issue":"Suppl 3","key":"10.1016\/j.actbio.2025.12.018_bib0011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bcpt.12626","article-title":"The role of the mucosa in normal and abnormal bladder function","volume":"119","author":"Fry","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.actbio.2025.12.018_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123307","article-title":"Innovative applications of natural polysaccharide polymers in intravesical therapy of bladder diseases","author":"Hu","year":"2025","journal-title":"Carbohydr. Polym."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0013","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.eursup.2011.06.001","article-title":"Glycosaminoglycan therapy for bladder diseases: emerging new treatments","volume":"10","author":"Bassi","year":"2011","journal-title":"Eur. Urol. Suppl."},{"issue":"8","key":"10.1016\/j.actbio.2025.12.018_bib0014","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00467-021-05239-w","article-title":"Urothelial progenitors in development and repair","volume":"37","author":"Jackson","year":"2022","journal-title":"Pediatr. Nephrol."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0015","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41385-022-00565-0","article-title":"The urothelium: a multi-faceted barrier against a harsh environment","volume":"15","author":"Jafari","year":"2022","journal-title":"Mucosal Immunol."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0016","doi-asserted-by":"crossref","first-page":"F1477","DOI":"10.1152\/ajprenal.00327.2009","article-title":"Cell biology and physiology of the uroepithelium","volume":"297","author":"Khandelwal","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0017","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00041.2019","article-title":"The urothelium: life in a liquid environment","volume":"100","author":"Dalghi","year":"2020","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1600-0854.2003.00156.x","article-title":"The uroepithelium: not just a passive barrier","volume":"5","author":"Apodaca","year":"2004","journal-title":"Traffic"},{"issue":"4\u20135","key":"10.1016\/j.actbio.2025.12.018_bib0019","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00418-005-0770-9","article-title":"Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation","volume":"123","author":"Kreft","year":"2005","journal-title":"Histochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00418-008-0492-x","article-title":"Rapid differentiation of superficial urothelial cells after chitosan-induced desquamation","volume":"131","author":"Veranic","year":"2009","journal-title":"Histochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/nau.22465","article-title":"Lamina propria: the functional center of the bladder?","volume":"33","author":"Andersson","year":"2014","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0022","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1464-410X.2003.03802.x","article-title":"The role of the human bladder lamina propria myofibroblast","volume":"91","author":"Wiseman","year":"2003","journal-title":"BJU Int."},{"key":"10.1016\/j.actbio.2025.12.018_bib0023","series-title":"Smooth Muscle Spontaneous Activity","first-page":"121","article-title":"Spontaneous activity and the urinary bladder","author":"Fry","year":"2019"},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0024","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ncb2956","article-title":"Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma","volume":"16","author":"Shin","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0026","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.hoc.2014.10.001","article-title":"Epidemiology of bladder cancer","volume":"29","author":"Malats","year":"2015","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0028","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11912-021-01091-1","article-title":"Approaches to non-muscle-invasive bladder cancer","volume":"23","author":"Slovacek","year":"2021","journal-title":"Curr. Oncol. Rep."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.actbio.2025.12.018_bib0030","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/PO.21.00115","article-title":"Identification of genetic risk factors for familial urinary bladder cancer: an exome sequencing study","volume":"5","author":"Pemov","year":"2021","journal-title":"JCO Precis. Oncol."},{"issue":"10061","key":"10.1016\/j.actbio.2025.12.018_bib0031","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.actbio.2025.12.018_bib0032","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina (B Aires)"},{"issue":"7","key":"10.1016\/j.actbio.2025.12.018_bib0033","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00262-023-03376-9","article-title":"Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer","volume":"72","author":"Semeniuk-Wojtas","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0034","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur. Urol. Oncol."},{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrurol.2014.52","article-title":"Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer","volume":"11","author":"Zargar","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"8","key":"10.1016\/j.actbio.2025.12.018_bib0036","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrurol.2014.130","article-title":"Landmarks in non-muscle-invasive bladder cancer","volume":"11","author":"Mertens","year":"2014","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0037","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.3692","article-title":"Efficacy, safety, and tolerability of pertuzumab, trastuzumab, and docetaxel for patients with early or locally advanced ERBB2-positive breast cancer in Asia: the PEONY phase 3 randomized clinical trial","volume":"6","author":"Shao","year":"2020","journal-title":"JAMA Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0038","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol."},{"issue":"10378","key":"10.1016\/j.actbio.2025.12.018_bib0039","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","article-title":"Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial","volume":"401","author":"de Langen","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s11864-023-01113-z","article-title":"Perioperative immunotherapy in muscle-invasive bladder cancer","volume":"24","author":"Singh","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0041","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/cancers15030566","article-title":"Current and future landscape of perioperative treatment for muscle-invasive bladder cancer","volume":"15","author":"Esteban-Villarrubia","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0042","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.actbio.2025.12.018_bib0043","first-page":"717","article-title":"Diagnosis and treatment of bladder cancer","volume":"80","author":"Sharma","year":"2009","journal-title":"Am. Fam. Phys."},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0044","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00120-020-01420-5","article-title":"Systemtherapie des harnblasenkarzinoms","volume":"60","author":"Tamalunas","year":"2021","journal-title":"Urologe"},{"issue":"7","key":"10.1016\/j.actbio.2025.12.018_bib0045","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2217\/nnm.14.212","article-title":"Nanotechnology in bladder cancer: current state of development and clinical practice","volume":"10","author":"Tomlinson","year":"2015","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0046","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.3390\/cancers13092214","article-title":"Nanotechnology in bladder cancer: diagnosis and treatment","volume":"13","author":"Barani","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2025.12.018_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114062","article-title":"Current advances in the application of nanomedicine in bladder cancer","volume":"157","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"18","key":"10.1016\/j.actbio.2025.12.018_bib0048","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202936","article-title":"Recent advances on cell culture platforms for in vitro drug screening and cell therapies: from conventional to microfluidic strategies","volume":"12","author":"Cardoso","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2025.12.018_bib0049","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2012.04.045","article-title":"Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy","volume":"164","author":"Mehta","year":"2012","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.actbio.2025.12.018_bib0051","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.2147\/IJN.S146927","article-title":"Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening","volume":"12","author":"Millard","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0052","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12935-023-03069-4","article-title":"Bladder cancer: therapeutic challenges and role of 3D cell culture systems in the screening of novel cancer therapeutics","volume":"23","author":"Farouk","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.actbio.2025.12.018_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119744","article-title":"Could 3D models of cancer enhance drug screening?","volume":"232","author":"Brancato","year":"2020","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.actbio.2025.12.018_bib0054","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.3390\/cancers15184466","article-title":"Preclinical testing techniques: paving the way for new oncology screening approaches","volume":"15","author":"van Rijt","year":"2023","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.actbio.2025.12.018_bib0055","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3390\/cells13242068","article-title":"A brief history of cell culture: from Harrison to organs-on-a-chip","volume":"13","author":"Moro","year":"2024","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.actbio.2025.12.018_bib0056","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.3390\/ijms21176225","article-title":"Spheroids as a type of three-dimensional cell cultures - examples of methods of preparation and the most important application","volume":"21","author":"Bialkowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.actbio.2025.12.018_bib0057","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tox.2008.03.020","article-title":"Immortalized human urothelial cells as a model of arsenic-induced bladder cancer","volume":"248","author":"Eblin","year":"2008","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0058","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eururo.2011.02.022","article-title":"Immortalisation of normal human urothelial cells compromises differentiation capacity","volume":"60","author":"Georgopoulos","year":"2011","journal-title":"Eur. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0059","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2013.07.021","article-title":"Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers","volume":"438","author":"Kohler","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0060","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.21873\/anticanres.13219","article-title":"Bladder organoids and spheroids: potential tools for normal and diseased tissue modelling","volume":"39","author":"Vasyutin","year":"2019","journal-title":"Anticancer Res."},{"issue":"22","key":"10.1016\/j.actbio.2025.12.018_bib0061","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212200","article-title":"3D cell culture systems: tumor application, advantages, and disadvantages","volume":"22","author":"Habanjar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0062","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tibtech.2016.08.004","article-title":"Life is 3D: boosting spheroid function for tissue engineering","volume":"35","author":"Laschke","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"8","key":"10.1016\/j.actbio.2025.12.018_bib0063","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3109\/14653249.2011.583233","article-title":"The liquid overlay technique is the key to formation of co-culture spheroids consisting of primary osteoblasts, fibroblasts and endothelial cells","volume":"13","author":"Metzger","year":"2011","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0064","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.5966\/sctm.2015-0412","article-title":"Mesenchymal stem cell spheroids retain osteogenic phenotype through alpha2beta1 signaling","volume":"5","author":"Murphy","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","article-title":"Scaffold-based 3D cell culture models in cancer research","volume":"31","author":"Abuwatfa","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0066","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1087057117696795","article-title":"Three-dimensional cell cultures in drug discovery and development","volume":"22","author":"Fang","year":"2017","journal-title":"SLAS Discov."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0067","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41416-023-02494-6","article-title":"Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation","volume":"130","author":"Viergever","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0068","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/CU9.0000000000000219","article-title":"Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy","volume":"17","author":"Jiang","year":"2023","journal-title":"Curr. Urol."},{"key":"10.1016\/j.actbio.2025.12.018_bib0069","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods. Primers"},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0070","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1002\/mco2.274","article-title":"Organoids: the current status and biomedical applications","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0071","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2025.12.018_bib0072","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.740574","article-title":"Research progress, challenges, and breakthroughs of organoids as disease models","volume":"9","author":"Huang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0073","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s13287-022-02950-9","article-title":"Organoids: a systematic review of ethical issues","volume":"13","author":"de Jongh","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.actbio.2025.12.018_bib0074","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.840674","article-title":"Organ-on-a-chip: a survey of technical results and problems","volume":"10","author":"Danku","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/bios14050225","article-title":"A comprehensive review of organ-on-a-chip technology and its applications","volume":"14","author":"Farhang Doost","year":"2024","journal-title":"Biosensors"},{"issue":"23","key":"10.1016\/j.actbio.2025.12.018_bib0076","article-title":"Organ-on-a-chip devices: technology progress and challenges","volume":"25","author":"Obeid","year":"2024","journal-title":"Chembiochem"},{"key":"10.1016\/j.actbio.2025.12.018_bib0077","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biotno.2024.01.001","article-title":"Organ-on-chip technology: opportunities and challenges","volume":"5","author":"Srivastava","year":"2024","journal-title":"Biotechnol. Notes"},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0078","doi-asserted-by":"crossref","DOI":"10.1002\/pat.70324","article-title":"3D bioprinting of biomaterials: a review of advances in techniques, materials, and applications","volume":"36","author":"Kandasamy","year":"2025","journal-title":"Polym. Adv. Technol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0079","article-title":"A review on cell damage, viability, and functionality during 3D bioprinting","volume":"9","author":"Xu","year":"2022","journal-title":"Mil. Med. Res"},{"issue":"4","key":"10.1016\/j.actbio.2025.12.018_bib0080","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/cancers13040874","article-title":"Organoid and spheroid tumor models: techniques and applications","volume":"13","author":"Gunti","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2025.12.018_bib0081","series-title":"Animal Biotechnology","first-page":"195","article-title":"Multicellular spheroid: 3-D tissue culture model for cancer research","author":"Khanna","year":"2014"},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0082","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1038\/s41598-019-43090-0","article-title":"Characterization of the physical properties of tumor-derived spheroids reveals critical insights for pre-clinical studies","volume":"9","author":"Guillaume","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2025.12.018_bib0083","doi-asserted-by":"crossref","DOI":"10.1038\/srep19103","article-title":"3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained","volume":"6","author":"Zanoni","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0084","first-page":"4923","article-title":"Impact of spheroid culture on molecular and functional characteristics of bladder cancer cell lines","volume":"18","author":"Yoshida","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0085","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.juro.2007.06.047","article-title":"Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C","volume":"178","author":"Speers","year":"2007","journal-title":"J. Urol."},{"issue":"13","key":"10.1016\/j.actbio.2025.12.018_bib0086","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201702858","article-title":"Multicellular tumor spheroids (MCTS) as a 3D in vitro evaluation tool of nanoparticles","volume":"14","author":"Lu","year":"2018","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.actbio.2025.12.018_bib0087","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/jphp.13145","article-title":"Assessing the cytotoxic potential of glycoalkaloidic extract in nanoparticles against bladder cancer cells","volume":"71","author":"Miranda","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.actbio.2025.12.018_bib0088","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fphys.2017.00605","article-title":"Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening","volume":"8","author":"Amaral","year":"2017","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0089","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1021\/acsnano.8b06610","article-title":"Targeting 3D bladder cancer spheroids with urease-powered nanomotors","volume":"13","author":"Hortel\u00e3o","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2025.12.018_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111460","article-title":"Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells","volume":"119","author":"Miranda","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.actbio.2025.12.018_bib0091","first-page":"775","article-title":"Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin","volume":"28","author":"Kamuhabwa","year":"2006","journal-title":"Int. J. Oncol."},{"issue":"12","key":"10.1016\/j.actbio.2025.12.018_bib0092","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3390\/cancers16122227","article-title":"Mechanisms of the antineoplastic effects of new fluoroquinolones in 2D and 3D human breast and bladder cancer cell lines","volume":"16","author":"Ferrario","year":"2024","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.actbio.2025.12.018_bib0093","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3390\/cells9122669","article-title":"Profiling and targeting of energy and redox metabolism in grade 2 bladder cancer cells with different invasiveness properties","volume":"9","author":"Pasquale","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.actbio.2025.12.018_bib0094","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1222411","article-title":"Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures","volume":"13","author":"Kloskowski","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.actbio.2025.12.018_bib0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001813-200207000-00002","article-title":"Selective cytotoxicity of gemcitabine in bladder cancer cell lines","volume":"13","author":"Kilani","year":"2002","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(03)00045-5","article-title":"Selective reovirus killing of bladder cancer in a co-culture spheroid model","volume":"93","author":"Kilani","year":"2003","journal-title":"Virus Res."},{"key":"10.1016\/j.actbio.2025.12.018_bib0097","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biomaterials.2017.08.041","article-title":"Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery","volume":"145","author":"Goulet","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2025.12.018_bib0098","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2023.11.023","article-title":"Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death","volume":"365","author":"Sun","year":"2024","journal-title":"J. Control. Rel."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0099","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/cancers12051304","article-title":"A simple three-dimensional in vitro culture mimicking the in vivo-like cell behavior of bladder patient-derived xenograft models","volume":"12","author":"Amaral","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2025.12.018_bib0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nprot.2008.226","article-title":"Spheroid-based drug screen: considerations and practical approach","volume":"4","author":"Friedrich","year":"2009","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0101","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00418-023-02224-2","article-title":"Selective targeting of lectins and their macropinocytosis in urothelial tumours: translation from in vitro to ex vivo","volume":"160","author":"Resnik","year":"2023","journal-title":"Histochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.actbio.2025.12.018_bib0102","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/biomedicines12081848","article-title":"Quantification of ions in human urine - a review for clinical laboratories","volume":"12","author":"Ferr\u00e3o","year":"2024","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0103","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0104","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.actbio.2025.12.018_bib0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2025.12.018_bib0106","article-title":"A robust immuno-prognostic model of non-muscle-invasive bladder cancer indicates dynamic interaction in tumor immune microenvironment contributes to cancer progression","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0107","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/ijms22031195","article-title":"Advanced multi-dimensional cellular models as emerging reality to reproduce in vitro the human body complexity","volume":"22","author":"Bassi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2025.12.018_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2024.342413","article-title":"Review: 3D cell models for organ-on-a-chip applications","volume":"1301","author":"Zuchowska","year":"2024","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0109","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.3390\/ijms23052662","article-title":"Engineering hydrogels for the development of three-dimensional in vitro models","volume":"23","author":"Maji","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.actbio.2025.12.018_bib0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrurol.2017.65","article-title":"The potential of organoids in urological cancer research","volume":"14","author":"Wang","year":"2017","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0111","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","article-title":"Bladder cancer organoids as a functional system to model different disease stages and therapy response","volume":"14","author":"Minoli","year":"2023","journal-title":"Nat. Commun"},{"issue":"9","key":"10.1016\/j.actbio.2025.12.018_bib0112","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202317613","article-title":"Patient-derived immunocompetent tumor organoids: a platform for chemotherapy evaluation in the context of T-cell recognition","volume":"63","author":"Zhao","year":"2024","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41698-023-00466-w","article-title":"Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer","volume":"7","author":"Garioni","year":"2023","journal-title":"NPJ Precis. Oncol."},{"issue":"17","key":"10.1016\/j.actbio.2025.12.018_bib0114","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3390\/cells12172188","article-title":"A protocol for organoids from the urine of bladder cancer patients","volume":"12","author":"Walz","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0115","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1039\/b820557b","article-title":"Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications","volume":"39","author":"Mark","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2025.12.018_bib0116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.copbio.2013.10.005","article-title":"Microfluidic cell culture","volume":"25","author":"Mehling","year":"2014","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.actbio.2025.12.018_bib0117","series-title":"Bio-Engineering Approaches to Cancer Diagnosis and Treatment","first-page":"219","article-title":"Application of microfluidics in cancer treatment","author":"Shahidian","year":"2020"},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0118","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.nantod.2009.12.001","article-title":"Microfluidic tools for cell biological research","volume":"5","author":"Velve-Casquillas","year":"2010","journal-title":"Nano Today"},{"issue":"34","key":"10.1016\/j.actbio.2025.12.018_bib0119","doi-asserted-by":"crossref","first-page":"36603","DOI":"10.18632\/oncotarget.5464","article-title":"Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment","volume":"6","author":"Bai","year":"2015","journal-title":"Oncotarget"},{"issue":"35","key":"10.1016\/j.actbio.2025.12.018_bib0120","doi-asserted-by":"crossref","first-page":"37695","DOI":"10.18632\/oncotarget.6070","article-title":"A bladder cancer microenvironment simulation system based on a microfluidic co-culture model","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.actbio.2025.12.018_bib0121","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1302983","article-title":"Prediction of anticancer drug resistance using a 3D microfluidic bladder cancer model combined with convolutional neural network-based image analysis","volume":"11","author":"Tak","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"3","key":"10.1016\/j.actbio.2025.12.018_bib0122","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1039\/C9LC00958B","article-title":"Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model","volume":"20","author":"Jeong","year":"2020","journal-title":"Lab Chip"},{"issue":"19","key":"10.1016\/j.actbio.2025.12.018_bib0123","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.7150\/thno.60851","article-title":"Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment","volume":"11","author":"Hong","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0124","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41420-022-01242-8","article-title":"Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells","volume":"8","author":"Mun","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.actbio.2025.12.018_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120477","article-title":"Therapeutic effect of decellularized extracellular matrix-based hydrogel for radiation esophagitis by 3D printed esophageal stent","volume":"266","author":"Ha","year":"2021","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.actbio.2025.12.018_bib0126","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1039\/C7BM00765E","article-title":"Bioinks for 3D bioprinting: an overview","volume":"6","author":"Gungor-Ozkerim","year":"2018","journal-title":"Biomater. Sci."},{"issue":"10","key":"10.1016\/j.actbio.2025.12.018_bib0127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223689","article-title":"Structure establishment of three-dimensional (3D) cell culture printing model for bladder cancer","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.actbio.2025.12.018_bib0128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3390\/mi13020277","article-title":"3D bioprinting of an in vitro model of a biomimetic urinary bladder with a contract-release system","volume":"13","author":"Chae","year":"2022","journal-title":"Micromachines"},{"issue":"1","key":"10.1016\/j.actbio.2025.12.018_bib0129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13206-022-00047-2","article-title":"Customized multilayered tissue-on-a-chip (MToC) to simulate Bacillus Calmette\u2013Gu\u00e9rin (BCG) immunotherapy for bladder cancer treatment","volume":"16","author":"Lee","year":"2022","journal-title":"BioChip J."},{"key":"10.1016\/j.actbio.2025.12.018_bib0130","first-page":"1","article-title":"An overview on materials and techniques in 3D bioprinting toward biomedical application","volume":"2","author":"Vanaei","year":"2021","journal-title":"Eng. Regen."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125009249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706125009249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:15:04Z","timestamp":1781507704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706125009249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":130,"alternative-id":["S1742706125009249"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.12.018","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling the human bladder tissue using three dimensional in vitro approaches as a tool for drug screening platforms","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}